Abstract
MicroRNAs are small non-coding RNA molecules which do not code for proteins, but control the expression of a significant proportion of the genome. The microRNA expression differences of normal and malignant tissue, as well as the differences in various tumor entities qualify this RNA species as biomarker for cancer patients. The detection of microRNAs in various bodily fluids stimulated research, and it was demonstrated for most human malignancies that tumorassociated microRNAs are detectable in patients circulation, thereby providing diagnostic and/or prognostic information.
Keywords: Biomarker, bladder cancer, diagnosis, microRNA, prostate cancer, renal cell carcinoma, testicular cancer.
Current Pharmaceutical Biotechnology
Title:MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies
Volume: 15 Issue: 5
Author(s): Jorg Ellinger and Stefan C. Muller
Affiliation:
Keywords: Biomarker, bladder cancer, diagnosis, microRNA, prostate cancer, renal cell carcinoma, testicular cancer.
Abstract: MicroRNAs are small non-coding RNA molecules which do not code for proteins, but control the expression of a significant proportion of the genome. The microRNA expression differences of normal and malignant tissue, as well as the differences in various tumor entities qualify this RNA species as biomarker for cancer patients. The detection of microRNAs in various bodily fluids stimulated research, and it was demonstrated for most human malignancies that tumorassociated microRNAs are detectable in patients circulation, thereby providing diagnostic and/or prognostic information.
Export Options
About this article
Cite this article as:
Ellinger Jorg and Muller C. Stefan, MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies, Current Pharmaceutical Biotechnology 2014; 15 (5) . https://dx.doi.org/10.2174/1389201015666140519124909
DOI https://dx.doi.org/10.2174/1389201015666140519124909 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents
Current Pharmaceutical Design Editorial [Hot Topic: Cancer Genetics (Guest Editor: Anirban Maitra)]
Current Molecular Medicine Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer <i>Via</i> Regulation of Inflammation: A Brief Review
Mini-Reviews in Medicinal Chemistry Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin
Current Medicinal Chemistry Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry SJSZ Glycoprotein (38 kDa) Inhibits Cell Cycle and Oxidative Stress in N-Methyl-N`- nitro-N-nitrosoguanidine-induced ICR Mice
Anti-Cancer Agents in Medicinal Chemistry Metallothioneins and Cancer
Current Protein & Peptide Science Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens
Current Pharmaceutical Design Cationic Polymer Optimization for Efficient Gene Delivery
Mini-Reviews in Medicinal Chemistry Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship
Current Medicinal Chemistry Healthy Properties of Garlic
Current Nutrition & Food Science Duloxetine in the Treatment of Depression: An Overview
Central Nervous System Agents in Medicinal Chemistry Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets Subject Index To Volume 6
Current Topics in Medicinal Chemistry A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry Application of the Shortest Path Algorithm for the Discovery of Breast Cancer-Related Genes
Current Bioinformatics VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets